Endocannabinoid
Resource Center
/ Most Recent /
To Help Patients Stop Smoking, Think CBD
For patients who struggle to quit smoking, there is a promising new natural solution — CBD. According to a study in Chemical Research in Toxicology,
Over-the-Counter CBD Products Are Often Mislabeled
Can you trust the labels on CBD products? According to a new study published in JAMA Open Network, the answer is maybe not. In a
Even at High Doses, CBD Is Driver-Safe
Ever wondered if it’s safe to drive when taking CBD? Australian researchers now have an answer to that question. According to a study in the
Could CBD Reduce COVID Lung Damage? A Protective Peptide May Be the Answer
Recent research shows that CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an
Experimental Mice Study Shows CBD May Reduce Plaque and Improve Cognition in Familial Alzheimer’s Model
Just as FDA is a new months away from making a ruling on the new drug aducanaumab that is reported to clear amyloid plaque, an
Cannabis May Not Be Right for Everyone – and That’s Okay
It’s true that not all cannabis products are right for everyone and, therefore cannot be used to treat everyone in the same way. We all
Actual THC or CBD Content is Often Different from What Consumers Expect, says JAMA Study
A buyer-beware study, from Massachusetts General Hospital (MGH), shows that medical cannabis products may be poorly labeled and do not always represent accurate levels of
Cannabis Users Need More Anesthesia During Surgery and Opioids in Recovery
Not only might cannabis users need more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice
Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at
Systematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing
Free Webinar: The Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids.
Healthcare professionals often have a knowledge gap when it comes to navigating the nascent hemp industry and providing evidence-based counseling to their communities. This webinar,
FDA Issues Consumer Warnings Statements About Cannabidiol
In November 2019 FDA issued a strong set of warning statements about cannabidiol. The agency said that “based on the lack of scientific information supporting
To Help Patients Stop Smoking, Think CBD
For patients who struggle to quit smoking, there is a promising new natural solution — CBD. According to a study in Chemical Research in Toxicology,
Over-the-Counter CBD Products Are Often Mislabeled
Can you trust the labels on CBD products? According to a new study published in JAMA Open Network, the answer is maybe not. In a
Even at High Doses, CBD Is Driver-Safe
Ever wondered if it’s safe to drive when taking CBD? Australian researchers now have an answer to that question. According to a study in the
Could CBD Reduce COVID Lung Damage? A Protective Peptide May Be the Answer
Recent research shows that CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an
Experimental Mice Study Shows CBD May Reduce Plaque and Improve Cognition in Familial Alzheimer’s Model
Just as FDA is a new months away from making a ruling on the new drug aducanaumab that is reported to clear amyloid plaque, an
Cannabis May Not Be Right for Everyone – and That’s Okay
It’s true that not all cannabis products are right for everyone and, therefore cannot be used to treat everyone in the same way. We all
Actual THC or CBD Content is Often Different from What Consumers Expect, says JAMA Study
A buyer-beware study, from Massachusetts General Hospital (MGH), shows that medical cannabis products may be poorly labeled and do not always represent accurate levels of
Cannabis Users Need More Anesthesia During Surgery and Opioids in Recovery
Not only might cannabis users need more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice
Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at
Systematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing
Free Webinar: The Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids.
Healthcare professionals often have a knowledge gap when it comes to navigating the nascent hemp industry and providing evidence-based counseling to their communities. This webinar,
FDA Issues Consumer Warnings Statements About Cannabidiol
In November 2019 FDA issued a strong set of warning statements about cannabidiol. The agency said that “based on the lack of scientific information supporting
